Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

437 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
cART durability and causes for treatment switching or discontinuation in HIV-positive patients older than 50 years of age.
Orlando G, Meraviglia P, Valsecchi L, Mainini A, Schiavini M, Merli S, Cordier L, Angeli E, Giorgi R, Atzori C, Dedivitiis G, Beretta R, Fasolo M, Zampini L, Gubertini G, Fasan M, Zambelli A, Gulisano C, Mazza F, Minisci D, Ricci E, Rizzardini G. Orlando G, et al. Among authors: rizzardini g. J Acquir Immune Defic Syndr. 2010 Oct;55(2):e12-4. doi: 10.1097/QAI.0b013e3181ef791b. J Acquir Immune Defic Syndr. 2010. PMID: 20859084 No abstract available.
Lopinavir/ritonavir pharmacokinetics in HIV/HCV-coinfected patients with or without cirrhosis.
Micheli V, Regazzi M, Dickinson L, Meraviglia P, Villani P, Khoo SH, Viganò P, Cordier L, Cusato M, Duca P, Orlando G, Rizzardini G, Back DJ, Cargnel A. Micheli V, et al. Among authors: rizzardini g. Ther Drug Monit. 2008 Jun;30(3):306-13. doi: 10.1097/FTD.0b013e318177209e. Ther Drug Monit. 2008. PMID: 18520602 Free PMC article. Clinical Trial.
Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients.
Morsica G, Bagaglio S, Cicconi P, Capobianchi MR, Pellizzer G, Caramello P, Orani A, Moioli C, Rizzardini G, Uberti-Foppa C, Puoti M, Monforte AD; Hepa I.C.o.N.A the Icona Foundation Study Groups. Morsica G, et al. Among authors: rizzardini g. J Acquir Immune Defic Syndr. 2009 Aug 15;51(5):574-81. doi: 10.1097/QAI.0b013e3181add592. J Acquir Immune Defic Syndr. 2009. PMID: 19590432
Predictability of sustained virological response to pegylated interferon alpha-2b Plus ribavirin therapy by week-8 viral response in HIV-positive patients with chronic hepatitis C virus infection.
Angeli E, Mainini A, Cargnel A, Uberti-Foppa C, Orani A, Carbone R, Andreoni M, Schiavini M, Giorgi R, Rizzardini G, Gubertini G; ICoS-2 Group. Angeli E, et al. Among authors: rizzardini g. Curr HIV Res. 2009 Jul;7(4):447-55. doi: 10.2174/157016209788680507. Curr HIV Res. 2009. PMID: 19601782 Clinical Trial.
Negative influence of HIV infection on day-night blood pressure variability.
De Socio GV, Bonfanti P, Martinelli C, Ricci E, Pucci G, Marinoni M, Vitiello P, Menzaghi B, Rizzardini G, Schillaci G. De Socio GV, et al. Among authors: rizzardini g. J Acquir Immune Defic Syndr. 2010 Nov;55(3):356-60. doi: 10.1097/QAI.0b013e3181e46456. J Acquir Immune Defic Syndr. 2010. PMID: 20562709
Pandemic influenza vaccine in adult HIV-1-infected patients.
Orlando G, Pariani E, Mazza F, Tanzi E, Meraviglia P, Gianelli E, Argenteri B, Amendola A, Galli M, Rizzardini G, Zanetti A. Orlando G, et al. Among authors: rizzardini g. AIDS. 2010 Aug 24;24(13):2142-3. doi: 10.1097/QAD.0b013e32833cfcb0. AIDS. 2010. PMID: 20679764 No abstract available.
437 results